Page last updated: 2024-10-31

myristicin and Carcinoma, Hepatocellular

myristicin has been researched along with Carcinoma, Hepatocellular in 1 studies

myristicin: asaricin is an isomer; structure; a methylene dioxy version of elemicin;

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"Myristicin is a natural active compound that has inflammatory, antimicrobial and anti-proliferative properties."1.62Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism. ( Bao, H; Muge, Q, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bao, H1
Muge, Q1

Other Studies

1 other study available for myristicin and Carcinoma, Hepatocellular

ArticleYear
Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism.
    Pharmaceutical biology, 2021, Volume: 59, Issue:1

    Topics: Allylbenzene Derivatives; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tu

2021